本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Collegium Pharmaceutical, Inc.

26.79
+0.01000.04%
盘后26.790.00000.00%16:20 EDT
成交量:21.44万
成交额:571.66万
市值:8.61亿
市盈率:14.43
高:27.09
开:26.60
低:26.22
收:26.78
数据加载中...
2024/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/22

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/22

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/03

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/08

重要事件披露

Form 8-K - Current report
2023/08/24

重要事件披露

Form 8-K - Current report
2023/08/10

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/07

重要事件披露

Form 8-K - Current report
2023/08/03

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]